Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

Felicetto Ferrara

doi:10.1002/hon.2046

Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

Hematological Oncology ◽

10.1002/hon.2046 ◽

2013 ◽

Vol 32 (1) ◽

pp. 1-9 ◽

Cited By ~ 19

Author(s):

Felicetto Ferrara

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Hypomethylating Agents ◽

Conventional Chemotherapy ◽

Acute Myeloid

Download Full-text

Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemia

British Journal of Haematology ◽

10.1111/bjh.14166 ◽

2016 ◽

Vol 178 (5) ◽

pp. 810-812 ◽

Cited By ~ 5

Author(s):

Lieke H. van der Helm ◽

Gerbrig Berger ◽

Arjan Diepstra ◽

Gerwin Huls ◽

Edo Vellenga

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Hypomethylating Agents ◽

Poor Survival ◽

Acute Myeloid

Download Full-text

Intensive compared with nonintensive chemotherapy in treating older patients with acute myeloid leukaemia or myelodysplastic syndrome

http://isrctn.org/> ◽

10.1186/isrctn62207270 ◽

2013 ◽

Author(s):

AK Burnett

Keyword(s):

Acute Myeloid Leukaemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukaemia ◽

Older Patients ◽

Acute Myeloid

Download Full-text

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

Leukemia ◽

10.1038/leu.2012.229 ◽

2012 ◽

Vol 27 (1) ◽

pp. 75-81 ◽

Cited By ~ 109

Author(s):

A K Burnett ◽

◽

R K Hills ◽

A E Hunter ◽

D Milligan ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Low Dose ◽

Remission Rate ◽

Gemtuzumab Ozogamicin ◽

Acute Myeloid

Download Full-text

Allo-HCT regimens with low toxicity needed in older patients with acute myeloid leukaemia

The Lancet Oncology ◽

10.1016/s1470-2045(15)00450-7 ◽

2016 ◽

Vol 17 (1) ◽

pp. e1

Author(s):

Mohamed A Kharfan-Dabaja ◽

Taiga Nishihori ◽

Ali Bazarbachi

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Low Toxicity ◽

Acute Myeloid

Download Full-text

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

The Lancet Haematology ◽

10.1016/s2352-3026(20)30209-x ◽

2020 ◽

Vol 7 (8) ◽

pp. e566-e574 ◽

Cited By ~ 1

Author(s):

Justin Taylor ◽

Xiaoli Mi ◽

Alexander V Penson ◽

Stella V Paffenholz ◽

Kelsey Alvarez ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Myelodysplastic Syndromes ◽

Hypomethylating Agents ◽

Phase 2 ◽

Single Centre ◽

Phase 2 Trial ◽

Acute Myeloid

Download Full-text

A trial for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome

http://isrctn.org/> ◽

10.1186/isrctn31682779 ◽

2013 ◽

Author(s):

Nigel Russell

Keyword(s):

High Risk ◽

Acute Myeloid Leukaemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukaemia ◽

Older Patients ◽

Acute Myeloid

Download Full-text

Allo-HCT regimens with low toxicity needed in older patients with acute myeloid leukaemia – Authors' reply

The Lancet Oncology ◽

10.1016/s1470-2045(15)00586-0 ◽

2016 ◽

Vol 17 (1) ◽

pp. e1-e2

Author(s):

Alessandro Rambaldi ◽

Arianna Masciulli ◽

Cristina Boschini

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Low Toxicity ◽

Acute Myeloid

Download Full-text

Outcomes of non‐myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission

Internal Medicine Journal ◽

10.1111/imj.15564 ◽

2021 ◽

Vol 51 (11) ◽

pp. 1954-1958

Author(s):

Phillip C. Nguyen ◽

Kate Manos ◽

Chun Y. Fong ◽

Anthony P. Schwarer ◽

Ing S. Tiong ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Allogeneic Stem Cell Transplant ◽

First Remission ◽

Acute Myeloid

Download Full-text

The value of molecular stratification forCEBPADMandNPM1MUTFLT3WTgenotypes in older patients with acute myeloid leukaemia

British Journal of Haematology ◽

10.1111/bjh.13873 ◽

2015 ◽

Vol 172 (4) ◽

pp. 573-580 ◽

Cited By ~ 10

Author(s):

Glenda J. Dickson ◽

Sophia Bustraan ◽

Robert K. Hills ◽

Akbar Ali ◽

Anthony H. Goldstone ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Molecular Stratification ◽

Acute Myeloid

Download Full-text

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽

10.1038/leu.2015.38 ◽

2015 ◽

Vol 29 (6) ◽

pp. 1312-1319 ◽

Cited By ~ 24

Author(s):

A K Burnett ◽

N Russell ◽

R K Hills ◽

N Panoskaltsis ◽

A Khwaja ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Nucleoside Analogue ◽

Older Patients ◽

Low Dose ◽

The Novel ◽

Low Dose Cytarabine ◽

Acute Myeloid

Download Full-text